From: Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt
Cases with available data | All patients | Patients without comorbidity | Patients with comorbidities | P-value | |
---|---|---|---|---|---|
CBC | |||||
Hemoglobin (g/dl) | 393 | 12.2 ± 2.0 | 12.6 ± 1.9 | 11.9 ± 2.0 | 0.001 |
Anemic (HB < 12) | 178 (45.3%) | 54 (35.8%) | 124 (51.2%) | 0.003 | |
WBCs (103/ul) | 405 | 9.2 ± 5.5 | 8.3 ± 4.8 | 9.8 ± 5.9 | 0.003 |
Low (< 4) | 46 (11.4%) | 23 (14.8%) | 21 (9.2%) | 0.014 | |
High (> 10) | 143 (35.3%) | 42 (27.1%) | 101 (40.4%) | ||
Neutrophil (%) | 315 | 68.1 ± 20.4 | 63.5 ± 20.9 | 70.5 ± 19.7 | 0.013 |
Low (< 40) | 26 (8.3%) | 13 (11.8%) | 13 (6.3%) | 0.029 | |
High (> 75) | 144 (45.7%) | 40 (36.4%) | 104 (50.7%) | ||
Lymphocytes (%) | 407 | 19.9 ± 14.6 | 23.0 ± 15.6 | 18.1 ± 13.7 | 0.001 |
Low (< 20) | 242 (59.8%) | 82 (53.6%) | 160 (63.5%) | 0.085 | |
Lymphocytes (103/ul) | 407 | 1.4 ± 0.98 | 1.5 ± 0.99 | 1.4 ± 0.98 | 0.301 |
Low (< 1.5) | 256 (62.9%) | 92 (59.7%) | 164 (64.8%) | 0.542 | |
Platelets (103/ul) | 391 | 275.2 ± 139.1 | 283.9 ± 118.7 | 269.8 ± 150.5 | 0.177 |
Low (< 140) | 37 (9.5%) | 4 (2.7%) | 33 (13.7%) | < 0.001 | |
High (> 450) | 37 (9.5%) | 10 (6.7%) | 27 (11.2%) | ||
INR | 256 | 1.1 ± 0.32 | 1.0 ± 0.12 | 1.1 ± 0.39 | 0.092 |
Ferritin (ng/ml) | 262 | 749.0 ± 997.4 | 698.9 ± 1137.5 | 777.9 ± 909.0 | 0.002 |
High (> 291) | 165 (63%) | 50 (52.1%) | 115 (69.3%) | 0.005 | |
d-dimer (mg/l) | 297 | 2.5 ± 8.7 | 1.3 ± 3.4 | 3.5 ± 11.1 | < 0.001 |
High (> 0.55) | 180 (60.6%) | 53 (41.7%) | 127 (74.7%) | < 0.001 | |
CRP (mg/dl) | 289 | 57.8 ± 74.1 | 43.0 ± 74.5 | 68.3 ± 72.2 | < 0.001 |
High (> 1) | 282 (97.6%) | 114 (95%) | 168 (99.4%) | 0.016 | |
PCR | |||||
Positive | 416 | 354 (85.1%) | 144 (88.9%) | 210 (82.7%) | 0.083 |
Negative | 43 (10.6%) | 18 (11.1%) | 44 (17.3%) |